Product Name: DNAPK (4010-4024)
Product Number: PE-01ARM99
Size: | 200 µg | | Price: | 51.00 |
| 1 mg | | $US | 102.00 |
| 5 mg | | | 224.00 |
Peptide Name: DNAPK (4010-4024)
Product Use: Services as a blocking peptide for use with the PRKDC-2 (DNAPK) rabbit polyclonal antibody (Cat. No.: AB-NK048-5) that is also available from Kinexus.
Peptide Production Method: Solid-phase peptide synthesis
Peptide Origin: Homo sapiens
Peptide Sequence: CSFDWKNFEQKMLKKG
Peptide Modifications N Terminus: Free amino
Peptide Modifications C Terminus: Amide
Peptide Molecular Mass Calculated: 1988.3 Da
Peptide Purity Percent after Synthesis and Purification: >95
Peptide Appearance: White powder
Scientific Background: DNAPK (PRKDC) is a protein-serine/threonine kinase of the Atypical group and PIKK family. Phosphorylation at -612, T2609, T2638, T2647 and T3950 inhibits phosphotransferase activity. DNAPK has been noted to be involved in sensing DNA damage, including DNA non-homologous end joining (NHEJ) and therefore, by association, be involved with V(D)J recombination events and double-strand break (DSB) repair. A possible scaffolding role of DNAPK for DNA-repair enzymes has also been proposed. DNAPK appears to be a tumour suppressor protein (TSP). The active form of the protein kinase normally acts to inhibit tumour cell proliferation until damage to DNA can be repaired. Therefore, it can play a role to facilitate tumour cell survival under conditions of radiation and chemotherapy.